Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥11.4bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥20.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥10.5bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥1.9bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥1.7bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥1.9bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥3.2bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.8bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥2.1bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥1.8bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥1.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥32.6bnat 2024-09-30Cons.Assets
Total assets¥31.5bnat 2024-03-31Cons.Assets
Total assets¥30.1bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥8.2bnat 2024-09-30Cons.Liabilities
Total liabilities¥7.9bnat 2024-03-31Cons.Liabilities
Net assets / equity¥24.4bnat 2024-09-30Cons.Net assets
Net assets / equity¥23.6bnat 2024-03-31Cons.Net assets
Net assets / equity¥22.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥15.7bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥14.0bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥15.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥13.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.8bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.0bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥1.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥883m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥149m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥703m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥998m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥985m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥170.42024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥280.512023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥155.762023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio70.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.7%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio71.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥1.4bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.4bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2024-04-01 → 2024-09-30¥9.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2024-04-01 → 2024-09-30¥9.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥11.4bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥11.4bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥1.9bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥194m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-09-30¥10.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥10.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 506
ItemContextValueUnit
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration729000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration1009000JPY
Other comprehensive incomePrior1YTDDuration158270000JPY
Other comprehensive incomeCurrentYTDDuration19452000JPY
Comprehensive incomePrior1YTDDuration1386338000JPY
Comprehensive incomeCurrentYTDDuration1470630000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration1286059000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration1310834000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration100279000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration159796000JPY
Income before income taxesPrior1YTDDuration1790855000JPY
Income before income taxesCurrentYTDDuration2099176000JPY
Depreciation and amortization ope cfPrior1YTDDuration208740000JPY
Depreciation and amortization ope cfCurrentYTDDuration224828000JPY
Amortization of goodwill ope cfPrior1YTDDuration18559000JPY
Amortization of goodwill ope cfCurrentYTDDuration18559000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-792000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration723000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration2436000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration12017000JPY
Increase decrease in provision for share based payments ope cfPrior1YTDDuration43300000JPY
Increase decrease in provision for share based payments ope cfCurrentYTDDuration44744000JPY
Increase decrease in net defined benefit liability ope cfPrior1YTDDuration18105000JPY
Increase decrease in net defined benefit liability ope cfCurrentYTDDuration11765000JPY
Increase decrease in provision for directors retirement benefits ope cfPrior1YTDDuration3939000JPY
Increase decrease in provision for directors retirement benefits ope cfCurrentYTDDuration-30141000JPY
Interest and dividends income ope cfPrior1YTDDuration-13591000JPY
Interest and dividends income ope cfCurrentYTDDuration-25932000JPY
Interest expenses ope cfPrior1YTDDuration1640000JPY
Interest expenses ope cfCurrentYTDDuration787000JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration-8514000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration-12303000JPY
Loss gain on sales of investment securities ope cfPrior1YTDDuration-22327000JPY
Loss gain on sales of investment securities ope cfCurrentYTDDuration-149274000JPY
Subsidy income2 ope cfPrior1YTDDuration-1049000JPY
Subsidy income2 ope cfCurrentYTDDuration-JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-398201000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration-484728000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-60461000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-12704000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-22973000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration17404000JPY
Increase decrease in advances received ope cfPrior1YTDDuration198362000JPY
Increase decrease in advances received ope cfCurrentYTDDuration193691000JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration-63182000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration-74023000JPY
Other net ope cfPrior1YTDDuration276968000JPY
Other net ope cfCurrentYTDDuration15032000JPY
Subtotal ope cfPrior1YTDDuration1971814000JPY
Subtotal ope cfCurrentYTDDuration1849623000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass